MedPage Today.
"Doctors and people receiving the vaccine should be aware that ischemic stroke can be a sign of VITT," he said. "Ischemic stroke as part of VITT needs to be recognized quickly because there are specific treatments, including immunoglobulins, plasma exchange, and anticoagulants, that can improve the outcome."
VITT is a rare syndrome associated with the AstraZeneca adenoviral vector vaccine, which uses a chimpanzee adenovirus-based vector. It is used in England and other countries but not the U.S. Cerebral venous sinus thrombosis also has been reported in people who received the Johnson & Johnson COVID-19 vaccine, which uses a human adenovirus-based vector.